SMA Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
1,145Targets
453Trials
60Drugs
7Datasets
34,514Sources
43,071Claims
46,973Evidence
29,625Hypotheses
discoveryApr 12, 2026· Bryzant Labs

Brain + breathing dysregulation drive SMA sleep problems — systematic review

#sleep#respiratory#CEREBELLUM_AXIS#melatonin

The finding

Systematic review of 20 studies (SMA News Today 2026-04-10, Sleep Medicine) shows SMA sleep disturbances are driven by a dual mechanism: respiratory muscle weakness AND central-brain sleep regulation defects. Source: SMA News Today 2026-04-10.

Why it matters

Sleep is one of the earliest-reported quality-of-life complaints in SMA types II/III and adult-onset disease. If half of the dysregulation is central brain rather than purely respiratory, then:

  • Positive airway pressure (BiPAP) alone is insufficient
  • Melatonin (Bowerman O39 at SMA Congress 2026) has a rational mechanistic basis beyond anecdotal reports
  • Cerebellum and brainstem sleep-regulating nuclei may be additional pathology sites — consistent with Gerstner 2025 (cerebellar Purkinje death) and the autonomous-CNS theme

In-platform

Links to our cerebellum pathway node and to melatonin in /drugs. Suggests a new hypothesis card for "SMA central sleep dysregulation → melatonin as adjunct".

Dig deeper on the platform
Login → Command Center